Entera Bio Ltd
For the period ended Dec 31, 2023. Filed Mar 8, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 8, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 14. Principal Accounting Fees and Services
| ITEM 14. | PRINCIPAL ACCOUNTING FEES AND SERVICES |
|---|
Kesselman & Kesselman (a member firm of PricewaterhouseCoopers International Limited) has served as our independent registered public accounting firm for 2023 and 2022. The following table sets forth fees billed to us by our independent registered public accounting firm during the fiscal years ended December 31, 2023 and 2022 for (i) services rendered for the audit of our annual financial statements and the review of our quarterly financial statements; and (ii) services rendered during the period in connection with tax compliance, tax advice and tax planning.
| Year EndedDecember 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Audit fees (1) | $157,500 | $194,000 |
| Tax fees (2) | 6,700 | 7,500 |
| Total fees | $164,200 | $201,500 |
| (1) | Includes professional services rendered in connection with the audit of our annual financial statements and the review of our interim financial statements and services related to certain registration statements. |
| (2) | Tax consulting services. |
Audit Committee Pre-approval Policies and Procedures
Our Audit Committee is responsible for pre-approving audit and non-audit services provided to us by our independent registered public accounting firm. All of the non-audit services provided to us by the independent auditors following the formation of our Audit Committee were pre-approved by the Audit Committee.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.